Understanding Acute Dietary Changes After GLP-1 Agonist Treatment: The GLaD Feasibility Study

Inclusion Criteria: * Aged 18+ years old * Intending to commence a prescription for a GLP-1 agonist (may be dual agonist, i.e. Ozempic, Trulicity, Monjaro, or Saxenda) medication, with no use in the previous 6 months * The primary reason for commencing the medication will be for diabetes or weight management * Willing to participate in dietary recall and questionnaires Exclusion Criteria: * Aged under 18 years, * used a GLP-1 agonist medication in the previous 6 months, * unwilling or unable to provide dietary recalls * non-English speaking.